The Epidemiology and Treatment of Ankylosing Spondylitis in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Seong-Ryul | - |
dc.contributor.author | Kim, Tae Hwan | - |
dc.contributor.author | Kim, Tae-Jong | - |
dc.contributor.author | Park, Won | - |
dc.contributor.author | Shim, Seung Cheol | - |
dc.date.accessioned | 2023-01-25T09:21:38Z | - |
dc.date.available | 2023-01-25T09:21:38Z | - |
dc.date.created | 2023-01-05 | - |
dc.date.issued | 2022-10 | - |
dc.identifier.issn | 2093-940X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/182199 | - |
dc.description.abstract | Ankylosing spondylitis is a chronic inflammatory disorder characterized by inflammation of the axial skeleton and sacroiliac joints and to a lesser extent by peripheral arthritis and the involvement of some extra-articular organs. It is paramount for the provision of effective health care delivery to be familiar with the epidemiologic studies on prevalence, mortality, and disability. Furthermore, there is no systematic arrangement of studies related to the treatment of ankylosing spondylitis in Korea. In this review, we addressed Korean ankylosing spondylitis epidemiological studies related to prevalence, genetic factor especially human leucocyte antigen-B27, extra-articular manifestations, infections, mortality, radiologic progression, child-birth, and quality of life. Furthermore, we reviewed Korean ankylosing spondylitis treatment researches about treatment trend, patients' registration program called The KOrean College of Rheumatology BIOlogics and targeted therapy (KOBIO) registry project, biologics and biosimiliars, complications especially infections, and issues about bony progression. There would be value to further studying the epidemiology and treatment of Korean ankylosing spondylitis. © 2022 by the Author(s). | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN COLL RHEUMATOLOGY | - |
dc.title | The Epidemiology and Treatment of Ankylosing Spondylitis in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Tae Hwan | - |
dc.identifier.doi | 10.4078/jrd.22.0023 | - |
dc.identifier.scopusid | 2-s2.0-85143874224 | - |
dc.identifier.wosid | 000898643000001 | - |
dc.identifier.bibliographicCitation | JOURNAL OF RHEUMATIC DISEASES (대한류마티스학회지), v.29, no.4, pp.193 - 199 | - |
dc.relation.isPartOf | JOURNAL OF RHEUMATIC DISEASES (대한류마티스학회지) | - |
dc.citation.title | JOURNAL OF RHEUMATIC DISEASES (대한류마티스학회지) | - |
dc.citation.volume | 29 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 193 | - |
dc.citation.endPage | 199 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002878397 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | NECROSIS-FACTOR INHIBITORS | - |
dc.subject.keywordPlus | RADIOGRAPHIC PROGRESSION | - |
dc.subject.keywordPlus | HLA-B27 SUBTYPES | - |
dc.subject.keywordPlus | CARDIOVASCULAR-DISEASE | - |
dc.subject.keywordPlus | PSORIATIC-ARTHRITIS | - |
dc.subject.keywordPlus | RHEUMATIC-DISEASES | - |
dc.subject.keywordPlus | POPULATION | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordAuthor | Ankylosing spondylitis | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Korea | - |
dc.identifier.url | https://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.22.0023 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.